TY - JOUR
T1 - New Alström syndrome phenotypes based on the evaluation of 182 cases
AU - Marshall, Jan D.
AU - Bronson, Roderick T.
AU - Collin, Gayle B.
AU - Nordstrom, Anne D.
AU - Maffei, Pietro
AU - Paisey, Richard B.
AU - Carey, Catherine
AU - MacDermott, Seamus
AU - Russell-Eggitt, Isabelle
AU - Shea, Sarah E.
AU - Davis, Judy
AU - Beck, Sebastian
AU - Shatirishvili, Gocha
AU - Mihai, Cristina Maria
AU - Hoeltzenbein, Maria
AU - Pozzan, Giovanni Battista
AU - Hopkinson, Ian
AU - Sicolo, Nicola
AU - Naggert, Jürgen K.
AU - Nishina, Patsy M.
PY - 2005/3
Y1 - 2005/3
N2 - Background: Alström syndrome is a recessively inherited genetic disorder characterized by congenital retinal dystrophy that leads to blindness, hearing impairment, childhood obesity, insulin resistance, and type 2 diabetes mellitus. We provide new details on cardiologic, hepatic, gastrointestinal, urologic, pulmonary, and neurobehavioral phenotypes in Alström syndrome and describe the histopathologic findings in 5 individuals. Methods: We obtained data on 182 patients from clinical examinations, medical record reviews, standardized questionnaires, and personal interviews with physicians and parents. Results: Dilated cardiomyopathy occurred in 60% of patients. Age at onset was either during infancy, often before vision disturbances were noted, or in adolescence or adulthood. There is a risk of recurrence of infantile cardiomyopathy. Hyperinsulinemia (92%) developed in early childhood and progressed to type 2 diabetes mellitus in 82% of those older than 16 years. Hypertriglyceridemia (54%) precipitated pancreatitis in 8 patients. Urologic dysfunction and gastrointestinal disturbances occurred in 48% and 35% of patients, respectively. Fifty-three percent of patients had persistent pulmonary symptoms. Neurologic symptoms in 20% of patients included clonic tic and absence seizures. Developmental motor or language delays were observed in 46% of patients. Fibrotic infiltrations of multiple organs, that is, kidney, heart, liver, lung, urinary bladder, gonads, and pancreas, were observed. Conclusions: The wide-ranging and complex spectrum of phenotypes reported herein broadens those previously described for Alström syndrome. These findings will aid physicians in making an early and accurate diagnosis and will help effect appropriate monitoring and treatment.
AB - Background: Alström syndrome is a recessively inherited genetic disorder characterized by congenital retinal dystrophy that leads to blindness, hearing impairment, childhood obesity, insulin resistance, and type 2 diabetes mellitus. We provide new details on cardiologic, hepatic, gastrointestinal, urologic, pulmonary, and neurobehavioral phenotypes in Alström syndrome and describe the histopathologic findings in 5 individuals. Methods: We obtained data on 182 patients from clinical examinations, medical record reviews, standardized questionnaires, and personal interviews with physicians and parents. Results: Dilated cardiomyopathy occurred in 60% of patients. Age at onset was either during infancy, often before vision disturbances were noted, or in adolescence or adulthood. There is a risk of recurrence of infantile cardiomyopathy. Hyperinsulinemia (92%) developed in early childhood and progressed to type 2 diabetes mellitus in 82% of those older than 16 years. Hypertriglyceridemia (54%) precipitated pancreatitis in 8 patients. Urologic dysfunction and gastrointestinal disturbances occurred in 48% and 35% of patients, respectively. Fifty-three percent of patients had persistent pulmonary symptoms. Neurologic symptoms in 20% of patients included clonic tic and absence seizures. Developmental motor or language delays were observed in 46% of patients. Fibrotic infiltrations of multiple organs, that is, kidney, heart, liver, lung, urinary bladder, gonads, and pancreas, were observed. Conclusions: The wide-ranging and complex spectrum of phenotypes reported herein broadens those previously described for Alström syndrome. These findings will aid physicians in making an early and accurate diagnosis and will help effect appropriate monitoring and treatment.
UR - http://www.scopus.com/inward/record.url?scp=20144362826&partnerID=8YFLogxK
U2 - 10.1001/archinte.165.6.675
DO - 10.1001/archinte.165.6.675
M3 - Review article
C2 - 15795345
AN - SCOPUS:20144362826
SN - 0003-9926
VL - 165
SP - 675
EP - 683
JO - Archives of Internal Medicine
JF - Archives of Internal Medicine
IS - 6
ER -